Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II randomized study of MenACWY-TT formulations versus Mencevax ACWY in healthy adolescents and young adults
2004-004248-37Phase 2Completed
- Sponsor
- GSK
- Start
- Jul 2005
- Modality
- Vaccines & Immunotherapeutics, Cytotoxic ADCs → Antibody-Drug Conjugates (ADCs) → Antibody Conjugates → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of meningococcal group A, C, W, and Y tetanus toxoid conjugate vaccine and meningococcal ACYW135 vaccine in meningococcal disease (5 arms), sponsored by GSK. Started Jul 2005; status: completed.
02
Drugs
meningococcal group A, C, W, and Y tetanus toxoid conjugate vaccinemeningococcal ACYW135 vaccine
03
Conditions
meningococcal disease
Beyond the preview
Go deeper on 2004-004248-37.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-004248-37.